Multicomponent Interventions to Improve Hepatitis B Vaccination Uptake Among Double-Negative Population

A substantial proportion of individuals identified through hepatitis B screening are double-negative (HBsAg-negative and anti-HBs-negative) and remain fully susceptible to hepatitis B virus (HBV) infection despite the availability of an effective vaccine. PubMed, Web of Science, and CNKI were searched for literature published between January 2000 and December 2025 on barriers to HBV vaccination in double-negative populations and the interventions addressing them. Barriers operate at individual (knowledge deficits, vaccine hesitancy), service delivery (geographic inaccessibility, financial burden, disconnected screening-to-vaccination pathways), and policy (weak provider incentives, insufficient cross-sector coordination) levels. Reported interventions comprise patient-oriented strategies (reminder and recall, Health Belief Model- and Theory of Planned Behavior-based education, community engagement), provider-oriented approaches (clinical decision support, vaccination incentives, Plan-Do-Study-Act cycles), and policy-level measures (controlled temperature chain, pay-it-forward, service decentralization). Multicomponent bundles may be complementary and produce greater effects than single components; however, direct head-to-head evidence in the double-negative population is limited. Double-negative status is a convergent end-point phenotype of three immunological trajectories (never-vaccinated, vaccine non-responders, and waned immunity), and interventions should therefore be stratified accordingly. A “Screening-Education-Vaccination-Follow-up” framework is proposed, and pragmatic cluster-randomized trials with nested cost-effectiveness analyses should be prioritized.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-11-18
DOI
https://doi.org/10.3390/vaccines14110996
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multicomponent Interventions to Improve Hepatitis B Vaccination Uptake Among Double-Negative Population

邓世洲, 何剑峰, Rong Cao, Guiyuan Ji et al.
3 links
Vaccines
Vaccine Coverage and Hesitancy
article

Multicomponent Interventions to Improve Hepatitis B Vaccination Uptake Among Double-Negative Population

邓世洲, 何剑峰, Rong Cao, Guiyuan Ji, Wei Wu, Jun Liu, Jianpeng Xiao, Shuaijing Zhang, Yunkai Lin, Jianhang Li, Xingfen Yang
article en

Abstract

A substantial proportion of individuals identified through hepatitis B screening are double-negative (HBsAg-negative and anti-HBs-negative) and remain fully susceptible to hepatitis B virus (HBV) infection despite the availability of an effective vaccine. PubMed, Web of Science, and CNKI were searched for literature published between January 2000 and December 2025 on barriers to HBV vaccination in double-negative populations and the interventions addressing them. Barriers operate at individual (knowledge deficits, vaccine hesitancy), service delivery (geographic inaccessibility, financial burden, disconnected screening-to-vaccination pathways), and policy (weak provider incentives, insufficient cross-sector coordination) levels. Reported interventions comprise patient-oriented strategies (reminder and recall, Health Belief Model- and Theory of Planned Behavior-based education, community engagement), provider-oriented approaches (clinical decision support, vaccination incentives, Plan-Do-Study-Act cycles), and policy-level measures (controlled temperature chain, pay-it-forward, service decentralization). Multicomponent bundles may be complementary and produce greater effects than single components; however, direct head-to-head evidence in the double-negative population is limited. Double-negative status is a convergent end-point phenotype of three immunological trajectories (never-vaccinated, vaccine non-responders, and waned immunity), and interventions should therefore be stratified accordingly. A “Screening-Education-Vaccination-Follow-up” framework is proposed, and pragmatic cluster-randomized trials with nested cost-effectiveness analyses should be prioritized.

VaccinesVol. 14(11)
Sun Yat-sen University (CN), Guangdong Provincial Center for Disease Control and Prevention (CN), Southern Medical University (CN)
Good health and well-being
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon